Breaking News Instant updates and real-time market news.

GILD

Gilead

$64.31

-0.38 (-0.59%)

10:55
05/25/17
05/25
10:55
05/25/17
10:55

Gilead participates in a conference call with Leerink

Leerink hosts a conference call with management on May 25 at 11:30 am.

  • 25

    May

GILD Gilead
$64.31

-0.38 (-0.59%)

04/25/17
JMPS
04/25/17
NO CHANGE
JMPS
Johsnson &Johnson data positive for Achillion, says JMP Securities
JMP Securities analyst Liisa Bayko says that data on a triple combination HCV treatment presented by Johnson & Johnson (JNJ) yesterday is positive for Achillion (ACHN). The analyst noted that the triple combination includes Achillion's odalasvir and that the six week treatment regimen is shorter than the eight weeks required for Gilead's (GILD) Harvoni. The analyst says that Achillion's stock dropped sharply yesterday because there was disappointment over the combination's efficacy in genotype 3 patients. However, she says that such patients only represent 10% of the total, and she says that Achillion can "conservatively" obtain peak royalty revenue of about $100M from its drug. Bayko keeps a $13 price target and an Outperform rating on the shares.
04/25/17
WELS
04/25/17
NO CHANGE
WELS
Gilead Q1 results poised to beat expectations, says Wells Fargo
After analyzing prescription data for January and February, Wells Fargo says that prescriptions of Gilead's HIV and HCV drugs were tracking ahead of expectations. The firm says the company's Q1 results appear on track to beat expectations.
04/21/17
PIPR
04/21/17
NO CHANGE
PIPR
Overweight
Piper Jaffray 'encouraged' by Gilead ACC inhibitor data in NASH
Piper Jaffray analyst Joshua Schimmer said Gilead's GS-0976 program in the treatment of NASH are the company's "most interesting" and the just announced data for the ACC inhibitor in a 10 patient study are very encouraging. The analyst, who continues to believe that reducing lipids is a key component for treating NASH, added that long term safety for inhibition of ACC will be necessary before he can have confidence in the program's potential. He keeps an Overweight rating on Gilead shares.
03/20/17
JEFF
03/20/17
NO CHANGE
JEFF
Buy
Jefferies uncovers 'unnoticed' positive NASH data coming from Gilead
Jefferies analyst Brian Abrahams said his review of titles for the upcoming EASL meeting of the International Liver Congress appears to indicate that Gilead's ACC inhibitor GS-0976, which he calls "one of [the company's] least-talked-about assets in NASH," demonstrated significant positive effects in an as-yet-unreported phase 2 study. The analyst, who calls the presentation "unnoticed" and "not broadly discussed," believes the study may meaningfully de-risk a second NASH asset and could set the stage for increasing enthusiasm around Gilead's NASH program over the next 12 months. Abrahams keeps a Buy rating on Gilead shares. The ILC meeting is being held from April 19 to 23 in Amsterdam.

TODAY'S FREE FLY STORIES

FIT

Fitbit

$5.61

-0.15 (-2.60%)

08:45
07/24/17
07/24
08:45
07/24/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SPI

SPI Energy

$0.54

-0.047 (-8.01%)

08:44
07/24/17
07/24
08:44
07/24/17
08:44
Hot Stocks
SPI Energy says Nasdaq grants request to extend stay of suspension in trading »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBIO

iBio

$0.32

-0.006 (-1.82%)

08:43
07/24/17
07/24
08:43
07/24/17
08:43
Hot Stocks
iBio enters into stock purchase agreement for up to $16M with LPC »

iBio announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$1.11

-0.01 (-0.89%)

08:43
07/24/17
07/24
08:43
07/24/17
08:43
Conference/Events
Cytori Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOH

Bank of Hawaii

$81.45

-0.52 (-0.63%)

08:42
07/24/17
07/24
08:42
07/24/17
08:42
Earnings
Bank of Hawaii reports Q2 EPS $1.05, consensus $1.03 »

Loan and lease balances…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JCP

J.C. Penney

$5.08

0.08 (1.60%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

08:40
07/24/17
07/24
08:40
07/24/17
08:40
Hot Stocks
J.C. Penney now accepts Apple Pay at all stores »

JCPenney (JCP) has rolled…

JCP

J.C. Penney

$5.08

0.08 (1.60%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

WWD

Woodward

$68.55

-0.87 (-1.25%)

08:39
07/24/17
07/24
08:39
07/24/17
08:39
Conference/Events
Woodward management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

SILC

Silicom

$51.37

0.96 (1.90%)

08:38
07/24/17
07/24
08:38
07/24/17
08:38
Conference/Events
Silicom management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

OTIV

On Track Innovations

$1.47

0.025 (1.74%)

08:38
07/24/17
07/24
08:38
07/24/17
08:38
Hot Stocks
On Track Innovations' Uno-8 contactless reader granted EMVCo Modular approval »

On Track Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

FNJN

Finjan Holdings

08:38
07/24/17
07/24
08:38
07/24/17
08:38
Hot Stocks
Finjan Holdings says oral arguments to be heard at Court of Appeals on Sep. 8 »

Finjan Holdings (FNJN),…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$38.46

-0.18 (-0.47%)

08:37
07/24/17
07/24
08:37
07/24/17
08:37
Conference/Events
PolyOne management to meet with Northcoast »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 31

    Jul

  • 01

    Aug

ARNC

Arconic

$25.21

0.46 (1.86%)

08:37
07/24/17
07/24
08:37
07/24/17
08:37
Earnings
Arconic sees FY17 EPS $1.15-$1.20, consensus $1.16 »

The company adjusted 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HIFR

InfraREIT

$19.90

0.2 (1.02%)

08:37
07/24/17
07/24
08:37
07/24/17
08:37
Hot Stocks
Breaking Hot Stocks news story on InfraREIT 

InfraREIT trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SLB

Schlumberger

$66.53

-0.49 (-0.73%)

08:36
07/24/17
07/24
08:36
07/24/17
08:36
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MED

Medifast

$42.11

0.28 (0.67%)

08:36
07/24/17
07/24
08:36
07/24/17
08:36
Hot Stocks
Medifast: Take Shape For Life rebrands to OPTAVIA »

Medifast announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

P

Pandora

$9.47

0.33 (3.61%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

08:36
07/24/17
07/24
08:36
07/24/17
08:36
Periodicals
Spotify near new licensing pact with Warner Music, Reuters reports »

Spotify and Warner Music…

P

Pandora

$9.47

0.33 (3.61%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 01

    Aug

  • 08

    Aug

  • 09

    Aug

  • 05

    Sep

HIFR

InfraREIT

$19.90

0.2 (1.02%)

08:35
07/24/17
07/24
08:35
07/24/17
08:35
Hot Stocks
InfraREIT announces agreement regarding dismissal of pending rate case »

InfraREIT announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

DMPI

DelMar Pharmaceuticals

$2.08

0.11 (5.58%)

08:34
07/24/17
07/24
08:34
07/24/17
08:34
Hot Stocks
DelMar Pharmaceuticals: HGRAC approves safety, efficacy study of VAL-083 »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

08:34
07/24/17
07/24
08:34
07/24/17
08:34
Conference/Events
Novocure management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 31

    Jul

ALV

Autoliv

$106.78

-9.11 (-7.86%)

08:34
07/24/17
07/24
08:34
07/24/17
08:34
Recommendations
Autoliv analyst commentary  »

Autoliv has reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

LMAT

LeMaitre

$28.31

-0.89 (-3.05%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Conference/Events
LeMaitre management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 31

    Jul

ARNC

Arconic

$25.21

0.46 (1.86%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Earnings
Arconic reports Q2 EPS ex-items 32c, consensus 26c »

Reports Q2 revenue $3.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

WU

Western Union

$19.09

0.01 (0.05%)

, BP

BP

$34.68

-0.42 (-1.20%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Hot Stocks
Western Union announces agreement with BP Australia »

The Western Union Company…

WU

Western Union

$19.09

0.01 (0.05%)

BP

BP

$34.68

-0.42 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

GRA

W.R. Grace

$72.17

1.12 (1.58%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Conference/Events
W.R. Grace management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 31

    Jul

  • 01

    Aug

PFE

Pfizer

$33.48

-0.06 (-0.18%)

08:32
07/24/17
07/24
08:32
07/24/17
08:32
Hot Stocks
Pfizer says Reflections B7391003 study met primary objective »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 02

    Aug

  • 03

    Aug

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.